How is myoma between uterine wall treated

Update Date: 2023-09-30 Source: Network

summary

Most people don't know about uterine intramural myoma, but many people will encounter it in their life. Therefore, we need to understand that uterine myoma is a common gynecological disease, a benign tumor, rarely malignant, but the harm to women can't be underestimated. Hysteromyoma has submucous myoma, intramural myoma, subserosal myoma, among which intramural myoma is a relatively common one, which also has a great impact on women. It can cause secondary anemia, infertility or abortion and other consequences. It is prone to infection, adhesion and inflammation. Therefore, it is necessary to treat intramural myoma in time. Let's share some experience.

How is myoma between uterine wall treated

First: intramural uterine fibroids often have vaginal bleeding, anemia or lower abdominal pain, which is very harmful to women. The treatment should be based on the patient's personal situation, such as the patient's age, fertility requirements, the growth rate of fibroids, etc.

Second: Generally speaking, for patients with small, small or asymptomatic intramural uterine fibroids, as well as those approaching menopause, these patients can be treated conservatively and reviewed regularly. For those with rapid growth of myoma, multiple myoma and symptoms such as pain or abnormal menstruation, surgical treatment can be considered.

Third: if the diameter of the patient's myoma has exceeded 4cm, and the possibility of malignant transformation can not be ruled out, there are obvious symptoms, which have hindered the patient's life, such as vaginal bleeding, abdominal pain or abdominal distension, accompanied by anemia symptoms or frequent urination, etc., the myoma can be surgically removed to prevent more harm.

matters needing attention

Uterine fibroids are easy to relapse, so patients with intramural fibroids, no matter what method of treatment they choose, should do regular review and pay attention to diet conditioning, in order to reduce the recurrence rate of uterine fibroids.